CareersInvestorsPressCorporate
Login
  1. Home
  2. Medical Imaging
  3. Magnetic Resonance Imaging
  4. MR Research Collaboration Program
Keyvisual

MR Research Collaboration Program Advancing MR Innovation Through Scientific Collaboration 

The MR Research Collaboration Program is a competitive research collaboration initiative from Siemens Healthineers Magnetic Resonance (MR).

The program supports investigator-driven scientific research within strategically defined research themes that align with future MR innovation priorities. Siemens Healthineers periodically publishes Strategic Research Collaboration Calls addressing high-priority scientific and clinical challenges.

Each call defines an umbrella research topic while allowing researchers the scientific freedom to propose their own innovative research questions, methodology and study design within such pre-defined field.

Our objective is to accelerate scientific innovation through transparent, competitive, and roadmap-aligned collaborations with the global MR research community.

Current Research Call

Research-Call-Microstructure MRI

One-Click Microstructure MRI 

Translating advanced diffusion microstructure MRI into robust, scalable research workflows

Application period:
October 15 - November 15, 2026

How to Apply

Interested researchers are invited to submit a proposal using the official application template after internal alignment with their employer, i.e. the institution.

Applications must be submitted electronically between October 15 - November 15, 2026 using the completed application template. The application should include:

  • Institute and principal investigator information
  • Project title
  • Project impact statement and project summary
  • Clinical or scientific background
  • Research objectives and hypothesis
  • Methodology and research approach
  • Expected outcomes, deliverables, and timeline of milestones
  • Supporting information
  • Support requested from Siemens Healthineers (non-financial)
  • Budget request
  • Data & AI considerations
  • System and technical context

Optionally, supporting documents such as selected publications may be attached where appropriate.

Application Timeline

01-Application-open.png

October 15, 2026

Call Opens

02-Application-Deadlline.png

November 15, 2026

Application Deadline 

03-Review.png

November 2026

Eligibility & Scientific Review 

Application & Review Process

Submit Proposal

Application-01.png

Applicants submit their proposal using the MR Research Collaboration Program Application Template. Only complete applications are eligible for review.

Application-02.png

Multi-step blinded review of project proposals taking into account the content and economic boundary conditions, including the proportionality of the requested funding relative to the proposed scope, expected impact and deliverables.

Application-03.png

Selection of highest-ranking/best-fitting project proposals within the available program budget and overall collaboration portfolio.

Collaboration-Agreement

Collaboration Agreement

Prior to the start of any project activities, Siemens Healthineers will provide the participating institution with a draft of a Siemens Healthineers Research Collaboration Agreement that details the contractual terms of the award, including the management of intellectual property, responsibility on clinical matters, confidentiality, project budget, payment schedule, requirements for progress reports, etc.

Project activities may only commence after all applicable agreements have been fully negotiated and executed.

Regulatory & Compliance Information

  • The MR Research Collaboration Program supports scientific research.
  • The published research topics are intended to encourage scientific investigation and collaboration. They are not intended to solicit product validation, performance evaluation, or regulatory studies.
  • Each participating institution is responsible for obtaining all applicable ethics approvals, institutional approvals and any approvals required under applicable national laws and regulations before commencing project activities.


  • Where the proposed research involves the use or investigation of a medical device, including investigational or research software or sequences, the applicable regulatory pathway must be assessed and described in the application (e.g., MDR, IRB study).
  • Selection of a project for the MR Research Collaboration Program does not constitute confirmation of the applicable regulatory classification or pathway, nor does it constitute regulatory or ethics approval.
  • Participation in this program and selection of a project does not replace or waive any applicable regulatory, ethical or institutional requirements.

Frequently Asked Questions

Academic hospitals, universities, and research institutions, or clinicians and scientists (after internal alignment with their employer, i.e. the institution) with relevant expertise in Magnetic Resonance research.

No. Applicants are encouraged to propose their own innovative scientific approach within the announced umbrella topic.

No. Applications are subject to a competitive review process taking scientific and economic factors into account. Only the highest-ranked proposals will be selected.
The submission of an application does not give rise to any legal or contractual right to receive funding, enter into a collaboration agreement, or obtain reimbursement of any costs associated with the application process. Siemens Healthineers reserves the right, in its sole discretion, to select, reject, or not consider any application. Satisfaction of the eligibility or evaluation criteria does not guarantee the award of a funding.

The requested budget is considered in the review process. Applicants are therefore encouraged to request a proportionate and well-justified budget that reflects the resources required to achieve the proposed objectives.
Funding efficiency and the relationship between requested funding, expected scientific impact and proposed deliverables may be considered as part of the overall evaluation.
If the requested budget exceeds the internal budget scope, Siemens Healthineers may either reject the application or provide a final and binding counteroffer. The submission of an application does not give rise to any legal or contractual right to receive funding.

The requested in-kind contribution is considered in the review process. Any in-kind contribution follows an internal approval process, taking into account regulatory, IP and confidentiality considerations.
The submission of an application does not give rise to any legal or contractual right to receive in-kind contribution.

No. Successful applicants will need to conclude a dedicated Research Collaboration Agreement with Siemens Healthineers before project initiation.

Country Eligibility

World Map

Institutions located in the following countries are currently not eligible to apply to the Siemens Healthineers MR Research Collaboration Program:

Afghanistan, Belarus, Cuba, Iran, Libya, Myanmar, North Korea, Russia, South Sudan, Sudan, Syria, Venezuela and Yemen. 

Eligibility may be subject to applicable sanctions, export control regulations and other legal or compliance requirements. Siemens Healthineers reserves the right to exclude applications where such restrictions apply.

Contact

MR Research Collaboration Program 
Magnetic Resonance 
Siemens Healthineers AG 
Siemensstr. 3 
91301 Forchheim 
Germany 

Application

Applications must be submitted electronically between October 15 - November 15, 2026 using the completed application template.

Apply now (pdf)